Management of diabetes during Ramadan

Diabetic Medicine

Volumn 22, Issue SUPPL. 4, 2005, Pages 21-23

  Whitelaw, D ^a  

^a BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; CHLORPROPAMIDE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN DERIVATIVE; ISOPHANE INSULIN; METFORMIN; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; TOLBUTAMIDE;

ADULT; BLOOD GLUCOSE MONITORING; CASE REPORT; DIET RESTRICTION; DRUG CONTRAINDICATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MALE; METABOLIC REGULATION; MOSLEM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; RELIGIOUS GROUP; REVIEW; TREATMENT PLANNING;

EID: 24044442247     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.1761g.x     Document Type: Review

References (23)

1. Barber SG, Fairweather S, Wright AD, Fitzgerald MG, Malins JM. Muslims, Ramadan and diabetes mellitus. BMJ 1979; ii: 46-47 (Letter).
2. Sulimani RA, Famuyiwa FO, Laajam MA. Diabetes mellitus and Ramadan fasting: the need for a critical appraisal. Diabet Med 1988; 5: 589-591.
3. Rashed AH. The fast of Ramadan. BMJ 1992; 304: 521-522.
4. Ahmed AF, Saleem Y, Abuaisha H. Ramadan fasting and insulin-dependent diabetes mellitus: effect on clinical and biochemical control. Int Diab Digest 1993; 4: 88-89.
5. Omar MAK, Motala AA. Fasting in Ramadan and the diabetic patient. Diabetes Care 1997; 20: 1925-26 (Letter).
6. Azizi F, Siahkolah B. Ramadan fasting and diabetes mellitus. Int J Ramadan Fasting Res 1998; 2: 8-17.
7. Uysal AR, Erdogan MF, Sahin G, Kamel N, Erdogan G. Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan. Diabetes Care 1998; 21: 2033-34 (Letter).
8. Yarahmadi S, Larijani B, Bastanhagh MH, Pajouhi M, Baradar Jalili R, Zahedi F et al. Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. J Coll Physicians Surg Pak 2003; 13: 329-332.
9. Sari R, Balci MK, Akbas SH, Avci B. The effects of diet, sulphonylurea and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res 2004; 30: 169-177.
10. The Glimepiride in Ramadan (GLIRA) Study Group. The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan. Diabetes Care 2005; 28: 421-422.
11. Davidson JC. Muslims, Ramadan and diabetes mellitus. BMJ 1979; ii: 1511-1512 (Letter).
12. Alghadyan AA. Retinal vein occlusion in Saudi Arabia: possible role of dehydration. Ann Ophthalmol 1993; 25: 394-398.
13. Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27: 2306-2311.
14. Khatib FA, Shafagoj YA. Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes mellitus patients in relation to food intake. Saudi Med J 2004; 25: 1858-1863.
15. Laajam MA. Ramadan fasting and non-insulin-dependent diabetes: effect on metabolic control. East Afr Med J 1990; 67: 732-736.
16. Salman H, Abdallah MA, Abanamy MA, Al Howasi M. Ramadan fasting in diabetic children in Riyadh. Diabet Med 1992; 9: 583-584 (Letter).
17. Akanji AO, Mojiminiyi OA, Abdella N. Beneficial changes in serum apo A-1 and its ratio to apo B and HDL in stable hyperlipidaemic subjects after Ramadan fasting in Kuwait. Eur J Clin Nutr 2000; 54: 508-513.
18. Feiig P, Lynch V. Starvation in human pregnancy: hypoglycaemia, hypoinsulinaemia and hyperketonaemia. Science 1970; 170: 990-992.
19. Belkhadir J, El Ghomari H, Klöcker N, Mikou A, Nasciri M, Sabri M. Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide. BMJ 1993; 307: 292-295.
20. Akram J, De Verga V and the Ramadan Study Group. Insulin lispro (Lys(B28), Pro(B29)) in the treatment of diabetes during the fasting month of Ramadan. Diabet Med 1999; 16: 861-866.
21. Kadiri A, Al Nakhi A, El Ghazali S, Jabbar A, Al Arouj M, Akram J et al. Treatment of type 1 diabetes with insulin lispro during Ramadan. Diabetes Metab 2001; 27: 482-486.
22. Mattoo V, Milicevic Z, Malone JK, Schwarzenhofer M, Ekangaki A, Levitt LK et al. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Diabetes Res Clin Pract 2003; 59: 137-143.
23. Mafauzy M. Repaglinide versus glibenclamide treatment of type 2 diabetes during Ramadan fasting. Diab Res Clin Pract 2002; 58: 45-53.